110 related articles for article (PubMed ID: 6276105)
21. [Pleural effusion].
Thomas P; Castelnau O; Kleisbauer JP
Rev Mal Respir; 1998 Jun; 15(3 Pt 2):363-7. PubMed ID: 9690306
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
23. Intensive combined modality therapy for limited-stage small-cell lung cancer.
Elias AD; Ayash L; Frei E; Skarin AT; Hunt M; Wheeler C; Schwartz G; Mazanet R; Tepler I; Eder JP
J Natl Cancer Inst; 1993 Apr; 85(7):559-66. PubMed ID: 8384264
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
[TBL] [Abstract][Full Text] [Related]
25. Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.
Li Y; Lian H; Jia Q; Wan Y
Biochem Biophys Res Commun; 2015 Feb; 457(2):177-82. PubMed ID: 25554695
[TBL] [Abstract][Full Text] [Related]
26. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.
Pettersson T; Klockars M; Fröseth B
Eur Respir J; 1988 Aug; 1(8):698-700. PubMed ID: 2853080
[TBL] [Abstract][Full Text] [Related]
27. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.
Patil T; Aisner DL; Noonan SA; Bunn PA; Purcell WT; Carr LL; Camidge DR; Doebele RC
Lung Cancer; 2016 Jun; 96():27-32. PubMed ID: 27133746
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer.
Lim E; Ali A; Theodorou P; Nicholson AG; Ladas G; Goldstraw P
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1113-8. PubMed ID: 15052210
[TBL] [Abstract][Full Text] [Related]
29. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
31. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
[TBL] [Abstract][Full Text] [Related]
32. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination.
Liu B; Liu L; Hu M; Qian K; Li Y
Thorac Cancer; 2016 Sep; 7(5):549-555. PubMed ID: 27766779
[TBL] [Abstract][Full Text] [Related]
33. Practical issues in the management of the patient with small cell lung cancer.
Govindan R; Ihde DC
Chest Surg Clin N Am; 1997 Feb; 7(1):167-81. PubMed ID: 9001763
[TBL] [Abstract][Full Text] [Related]
34. Pleural effusion in breast cancer: influence upon clinical course and survival.
Singer TS; Sulkes A; Biran S
Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
[TBL] [Abstract][Full Text] [Related]
35. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
37. Management of small cell lung cancer.
Seidenfeld J; Samson DJ; Bonnell CJ; Ziegler KM; Aronson N
Evid Rep Technol Assess (Full Rep); 2006 Jul; (143):1-154. PubMed ID: 17764204
[TBL] [Abstract][Full Text] [Related]
38. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and staging of lung cancer].
Serke M; Schönfeld N
Dtsch Med Wochenschr; 2007 May; 132(21):1165-9. PubMed ID: 17506012
[TBL] [Abstract][Full Text] [Related]
40. [Carbohydrate antigens in pleural effusion from patients with lung cancer].
Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
